All staff at the CDC responsible for tracking outbreaks of hepatitis, antibiotic-resistant gonorrhea, chlamydia, and syphilis were laid off.

Explore seven biotech companies advancing clinical drugs in the race for regulatory approval to revolutionize hepatitis B ...

Gain valuable insights into novel therapies, ongoing clinical trials, and future innovations shaping the treatment of ...

Fatigue and yellowing eyes may signal hepatitis, a serious liver issue. Learn the symptoms, causes, prevention, and available ...

Viral hepatitis was the most common cause of infectious disease mortality worldwide after tuberculosis in 2024, according to ...

Premium InsightsThe Hepatitis C drug market is entering a transformative phase as global health organizations, pharmaceutical ...

Credit: Dalin Ou via Getty Images. US biotech Merida Biosciences has launched with $121m in Series A financing to develop therapeutics targeting disease-causing antibodies in autoimmune diseases and ...

State Key Laboratory of Medical Proteomics, Dalian Institute of Chemical Physics, Chinese Academy of Sciences, Dalian 116023, China University of Chinese Academy of Sciences, Beijing 101408, China ...

Over 300 cases of hepatitis A have been reported so far ... has resulted in a growing number of people without protective antibodies who are highly susceptible to infection. This mainly concerns ...

That’s what happens in Antiphospholipid Antibody Syndrome (APS). It’s a health issue most people haven’t heard of, but it can lead to serious problems like blood clots, strokes, and ...

The greatest distributors of hepatitis A virus are children. When they become infected with the virus, they do not get very sick — usually not sick enough to exhibit jaundice — but they ...